Skip to main content
. 2020 Oct 23;12(11):3239. doi: 10.3390/nu12113239

Table 4.

The most common adverse events reported over 52 weeks in participants allocated to PGX® or placebo.

PGX® (n = 103) Placebo (n = 104)
Total adverse events 580 525
Most common events:
Diarrhoea/loose stool 150 61
Cold/flu-like symptoms 56 71
Abdominal bloating 35 29
Abdominal pain/cramps 35 37
Constipation 17 48
Headache/sinus pain 27 45

Abbreviations: PGX®—PolyGlycopleX®. Data from Reimer et al. [31].